Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation
Qiuyun Li,1,* Hui Gao,2,* Huawei Yang,1 Wei Wei,1 Yi Jiang11Department of Breast Surgery, The Affiliated Tumor Hospital of Guangxi Medical University, Nanning, Guangxi 530021, People’s Republic of China; 2Department of Breast Surgery, Ruikang Hospital Affiliated to Guangxi University of Ch...
Main Authors: | Li Q, Gao H, Yang H, Wei W, Jiang Y |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/-estradiol-promotes-the-progression-of-er-breast-cancer-through-peer-reviewed-article-OTT |
Similar Items
-
Phosphorylation of p90RSK is associated with increased response to neoadjuvant chemotherapy in ER-positive breast cancer
by: Moon Hyeong-Gon, et al.
Published: (2012-12-01) -
RSK Isoforms in Acute Myeloid Leukemia
by: Minyoung Youn, et al.
Published: (2021-06-01) -
Identifying requirements for RSK2 specific inhibitors
by: Eric B. Wright, et al.
Published: (2021-01-01) -
A rising cancer prevention target of RSK2 in human skin cancer
by: Arul eNarayanasamy, et al.
Published: (2013-08-01) -
Effect of RSK4 on Biological Characteristics of Gastric Cancer
by: Hu C, et al.
Published: (2020-01-01)